M1-like TAMs are required for the efficacy of PD-L1/PD-1 blockades in gastric cancer

The efficacy of PD-1/PD-L1 blockades is heterogeneous in different molecular subtypes of gastric cancer (GC). In this study, we analyzed relevant clinical trials to identify the molecular subtypes associated with the efficacy of PD-1/PD-L1 blockades, and public datasets, patient samples, and GC cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Rui, Wan, Qianyi, Wang, Yong, Wu, Yutao, Xiao, Shuomeng, Li, Qiqi, Shen, Xiaoding, Zhuang, Wen, Zhou, Yong, Xia, Lin, Song, Yinghan, Chen, Yi, Yang, Hanshuo, Wu, Xiaoting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781754/
https://www.ncbi.nlm.nih.gov/pubmed/33457080
http://dx.doi.org/10.1080/2162402X.2020.1862520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781754/
https://www.ncbi.nlm.nih.gov/pubmed/33457080
http://dx.doi.org/10.1080/2162402X.2020.1862520

Ejemplares similares